Company Profile

IMB (Hong Kong) Limited

Company overview

JobsDB Company Profiles
IMB(HONG KONG) LIMITED was registered in the Hong Kong Science Park in August 2016 and specializes in “Universal Tumor Precision Preventive” medical services. The company has exclusively introduced the German Zyagnum AG “EDIM Artificial Intelligence Detection Technology” and relevant medical technology from German Duale Medizin hospital, jointly developed “PT Tumor-Localizing Detection Biotechnology” with the State Key Laboratory of Molecular Oncology, Cancer Hospital of the Chinese Academy of Medical Sciences, jointly developed “Cancer prevention immunotherapy”, “Cancer Immunization Precision Immune Biotechnology” with the Biotherapy Center of Beijing Hospital, and independently developed “PT Tumor-Localizing Artificial Intelligence Interpretation System” and “NCWorld Service Operation System”. Through the introduction of international advanced technology in combination with joint development of innovative technologies and independent research and development of technology, the company has established a comprehensive technical system of universal tumors from automated detection, intelligent tracking of precancerous lesions to the prevention and treatment of cancers. The company provides one-stop online and offline medical service of “Accurate and Precise Preventive Treatment of universal tumor” for users in cooperation with NCWorld Medical Center in Hong Kong, Duale Medizin Hospital in Germany and Biovis Diagnostik Laboratory in Germany through “NCWorld Service Operation System”. Add: Unit 501, 5/F, Building 20E, No.20 Science Park East Avenue, HKSP, Pak Shek Kok, New Territories, Hong Kong Tel: 00852-3718 0325 Contacts: Ip Ting Fung
< 50 Employees
Double Pay, Medical Insurance, Performance Bonus, Five-day work week